Our xTAG® and MultiCode™-RTx Technologies serve a wide range of clinical applications, providing exceptional sensitivity and specificity, unmatched throughput flexibility, and increased assay speed.
Read More
Our xMAP® Technology and its flexible, open-architecture design is used in a wide variety of applications, from academic and clinical research to biodefense and clinical diagnostics.
Read More
Our Business Development team invites you to contact them to explore your potential development and commercialization applications using our xMAP® technology. Click here to start the conversation now.
Learn More
The Faces of Luminex: Jen Dillman, Product Development
There are a lot of steps between having the idea for a new product and actually making the product for commercial release. Here at Luminex, we count on people like Jen Dillman, Senior Manager of Product Development, to help get new products across the finish line.
Continue Reading >
xMAP Technology makes up the basis of Luminex’s core business. This flexible technology is centered on the use of Luminex xMAP Microspheres.
Watch more videos >
March 5
Luminex Corporation to Present at the Barclays Global Healthcare Conference
February 8
Luminex Corporation Declares First Quarter Cash Dividend
February 4
Luminex Corporation Reports Fourth Quarter and Full-Year 2018 Financial Results
January 2
Luminex Corporation Completes Acquisition of MilliporeSigma’s Flow Cytometry Portfolio
November 5
Luminex Corporation Reports Third Quarter 2018 Financial Results
ECCMID
13-16 April
Amsterdam, Netherlands
Oxford Immunology Symposium
23-24 April
Oxford, UK
12th Annual Proteins & Antibodies Congress
24-25 April
London, UK
